Get informed when a big investor buys or sells
+ FollowOctober 29, 2026 - AI Summary
Loading insider trades…
Loading congress trades…
| Market cap | $326.68 Million |
|---|---|
| Enterprise Value | $35.56 Billion |
| Dividend yield | 3.97% |
| Earnings per Share | $3.46 |
| Beta | -0.47 |
| Outstanding Shares | 2,043,000,000 |
| P/E Ratio | 14.03 |
|---|---|
| PEG | -791.98 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.71 |
| Enterprise Value to EBIT | 3.48 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 1.26 |
| Debt to Equity | 1.91 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 0.01% |
|---|---|
| Total Invested | $19,504▼ 26.39% |
| Investors Holding | 7▼ 7.00% |
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse p...
Stockcircle shows 3 open-market insider sales for Bristol-Myers Squibb Company Ce in the last six months from SEC Form 4 reports by executives, directors, and other insiders.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.